FIELD: medicine; pharmacology.
SUBSTANCE: therapeutic combination includes Voriconazole and antimycotic inhibitor CYP2C19 Fluconazole. Besides, invention refers to composition, set, unit-dosed form, including the specified components, as well as to method of mycotic infection treatment.
EFFECT: lower metabolism in extensive metaboliser of Voriconazole, synergetic effect developed by introduction of the specified combination.
7 cl, 12 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IDENTIFICATION OF PATIENTS' REACTION TO ADMINISTRATION OF S1P RECEPTOR MODULATOR | 2013 |
|
RU2785736C2 |
| COMPOSITIONS AND METHODS OF TREATING RHINOSINUSITIS | 2004 |
|
RU2410083C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PHENYLAMIDINE DERIVATIVE, AND METHOD OF USING PHARMACEUTICAL COMPOSITION IN COMBINATION WITH ANTIMYCOTIC | 2007 |
|
RU2429843C2 |
| COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS | 2021 |
|
RU2824066C1 |
| PHARMACEUTICAL PREPARATION | 2017 |
|
RU2760681C2 |
| NOVEL DOSAGE FORM FOR TREATING MYCOTIC INFECTION | 2010 |
|
RU2481100C2 |
| USE OF COMPOUNDS IN TREATING FUNGAL INFECTIONS | 2021 |
|
RU2805930C1 |
| METHODS FOR TREATMENT OF GAUCHER DISEASE | 2018 |
|
RU2781242C2 |
| THERAPY OF MYCOSES | 2005 |
|
RU2380116C2 |
| PHARMACEUTICAL COMBINATION AND METHOD FOR APPLICATION OF ANTIFUNGAL PREPARATION IN COMBINATION | 2006 |
|
RU2396955C2 |
